Jasper Therapeutics Inc (JSPR)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | WIGGANS, THOMAS G | Director | Stock Option (Right to Buy | Acquisition | 7,500 | 0 |
| Jul 31, 2026 | SHIZURU, JUDITH ANNE | Director | Stock Option (Right to Buy | Acquisition | 7,500 | 0 |
| Jul 31, 2026 | LUCAS, SVETLANA | Director | Stock Option (Right to Buy | Acquisition | 7,500 | 0 |
| Jul 31, 2026 | CRUTCHER, PATRICK J | Director | Stock Option (Right to Buy | Acquisition | 7,500 | 0 |
| Jul 31, 2026 | EMSTER, KURT VON | Director | Stock Option (Right to Buy | Acquisition | 7,500 | 0 |
| Jul 20, 2026 | ROS, MATTHEW E | Chief Operating Officer | Non-Voting Convertible Preferred Stock | Acquisition | 881 | |
| Jul 20, 2026 | CRUTCHER, PATRICK J | Director | Non-Voting Convertible Preferred Stock | Acquisition | 888 | |
| Jul 16, 2026 | CRUTCHER, PATRICK J | Director | Stock Option (Right to Buy | Acquisition | 15,000 | 0 |
| Feb 6, 2026 | MAHAL, JEETINDER SINGH | Director, CEO and President | Stock Option (right to buy) | Acquisition | 500,000 | 0 |
| Jan 2, 2026 | MARTELL, RON | Director, President, CEO and Director | Stock Option (right to buy) | Acquisition | 234,000 | 0 |
| Jan 2, 2026 | MAHAL, JEETINDER SINGH | Chief Operating Officer | Stock Option (right to buy) | Acquisition | 90,000 | 0 |
| Jan 2, 2026 | CROSS, HERB | Chief Financial Officer | Stock Option (right to buy) | Acquisition | 90,000 | 0 |